Apg Asset Management N.V. Nektar Therapeutics Transaction History

Apg Asset Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$14.47 - $27.96 $15,917 - $30,756	-1,100 Reduced 2.02%	53,300 $1.6 Million
Q4 2019 Feb 13, 2020	SELL	$15.87 - $23.12 $1.82 Million - $2.65 Million	-114,560 Reduced 67.8%	54,400 $1.05 Million
Q3 2019 Nov 08, 2019	BUY	$16.91 - $36.27 $1.96 Million - $4.19 Million	115,660 Added 217.0%	168,960 $2.82 Million
Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $273,870 - $509,850	9,000 Added 20.32%	53,300 $1.53 Million
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $2.05 Million - $4.63 Million	44,300 New	44,300 $1.85 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.